On (b)(6) 2020, a patient (pt) in (b)(6) reported a diagnosis of keratitis od while wearing an acuvue® vita¿ brand contact lens.The pt experienced redness and discharge in the od while wearing one contact lens in (b)(6) 2020.The pt¿s od was still red upon removal of the lens.The pt visited the eye care provider (ecp) and was diagnosed with keratitis od.The pt was prescribed levofloxacin eye drops to use every hour and chlortetracycline hydrochloride eye ointment to use before bed.On 10aug2020, additional information was received from the pt: the pt reported that the ecp advised that there is a ¿possibility of scarring on cornea.¿ the pt will return to the ecp for a follow-up next week.No further information was provided.On 12aug2020, additional information was received from the pt: the pt reported that the medications changed to levofloxacin eye drops to use 3-4 times a day; levofloxacin eye gel once before bed; chlortetracycline hydrochloride eye ointment was discontinued.The pt was willing to provide the medical report when the symptoms resolve.The pt was unable to provide any further information.No additional medical information has been received.The suspect od contact lens was discarded.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot b00v7tw was produced under normal conditions.If any further relevant information is received, a supplemental report will be filed.
|